MedTrace Logo

Tomosynthesis Mammographic Imaging Screening Trial

NCT02616432 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3065

Last updated 2025-05-21

No results posted yet for this study

Summary

A randomized screening trial to compare the diagnostic accuracy of screening for breast cancer with three-dimensional digital breast tomosynthesis (DBT) plus two-dimensional full-field digital mammography (FFDM) versus FFDM alone.

Conditions

Interventions

DEVICE

Tomosynthesis

Three-dimensional imaging of both breasts in standard CC and MLO views

Sponsors & Collaborators

  • Eastern Cooperative Oncology Group

    collaborator NETWORK

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Roberta A Jong, MD · Sunnybrook Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02616432 on ClinicalTrials.gov